Literature DB >> 29843100

A novel NAE/UAE dual inhibitor LP0040 blocks neddylation and ubiquitination leading to growth inhibition and apoptosis of cancer cells.

Peng Lu1, Yahui Guo2, Lijuan Zhu1, Yineng Xia1, Yuejiao Zhong3, Yubin Wang4.   

Abstract

NEDD8 activating enzyme (NAE) plays an important role in regulating intracellular proteins with key parts in a broad array of cellular functions. On the basis of previously work, a series of 2H-chromen-2-one based NAE inhibitors were designed and synthesized. Through enzyme-based and cell-based assays, LP0040 was identified as a non-nucleoside NAE/UAE dual inhibitor. It could inhibit NAE/UAE activities and downregulated degradations of related substrates in AGS cells, promoting apoptosis in low micromole concentrations. LP0040 possessed anti-proliferation activities with IC50 values of 0.76-3.29 μM against multiple human cancer lines and had synergistic effect with bortezomib. Thus LP0040 represented valuable starting points for future development of NAE/UAE dual inhibitors.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; Drug discovery; Dual inhibitor; NEDD8 activating enzyme; Ubiquitin activating enzyme

Mesh:

Substances:

Year:  2018        PMID: 29843100     DOI: 10.1016/j.ejmech.2018.05.027

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  4 in total

Review 1.  A patent review of the ubiquitin ligase system: 2015-2018.

Authors:  Xin Li; Ekinci Elmira; Sagar Rohondia; Jicang Wang; Jinbao Liu; Q Ping Dou
Journal:  Expert Opin Ther Pat       Date:  2018-11-23       Impact factor: 6.674

Review 2.  Anticancer drug discovery by targeting cullin neddylation.

Authors:  Qing Yu; Yihan Jiang; Yi Sun
Journal:  Acta Pharm Sin B       Date:  2019-09-20       Impact factor: 11.413

3.  Small molecules targeting the NEDD8·NAE protein-protein interaction.

Authors:  Chen-Ming Lin; Zhengyang Jiang; Zhe Gao; Maritess Arancillo; Kevin Burgess
Journal:  Chem Sci       Date:  2020-12-14       Impact factor: 9.825

Review 4.  Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer.

Authors:  Trace M Jones; Jennifer S Carew; Julie E Bauman; Steffan T Nawrocki
Journal:  Cancers (Basel)       Date:  2021-06-29       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.